Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xylose-containing oligosaccharides are a functional class of carbohydrates characterized by the presence of xylose residues, most notably found in plant-derived xylo-oligosaccharides (XOS) and as part of the core structure of various glycoproteins and proteoglycans. In human health, these molecules primarily function as prebiotics, where they are selectively fermented by beneficial gut bacteria such as Bifidobacterium, leading to the production of short-chain fatty acids that support intestinal barrier function and immune homeostasis (Aachary & Prapulla, 2011). Furthermore, specific xylose-containing N-glycans serve as the initial linkage unit for glycosaminoglycans on proteoglycans, playing a vital role in the structural integrity of the extracellular matrix (Prydz & Dalen, 2000). In the field of immunology, these structures are recognized as cross-reactive carbohydrate determinants (CCDs) that can elicit IgE responses, frequently causing diagnostic challenges by producing false-positive results in allergy tests (Altmann, 2016). While they are being investigated for their role in managing metabolic and inflammatory conditions via microbiome modulation, they are categorized as a chemical class rather than a discrete therapeutic target protein. Consequently, their pharmacological relevance lies in their use as dietary supplements or their role as interfering epitopes in diagnostics rather than as sites for traditional small-molecule drug binding (Bax et al., 2015).
Xylose-containing oligosaccharides primarily act as prebiotics that undergo fermentation by anaerobic bacteria in the colon, such as Bifidobacterium, to produce short-chain fatty acids (Aachary & Prapulla, 2011). In an immunological context, they function as epitopes (CCDs) for IgE antibodies, leading to cross-reactivity in allergic sensitization (Altmann, 2016).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xylose-containing oligosaccharides (XOS).